176 related articles for article (PubMed ID: 37265789)
1. Prognostic impact of the loss of E-cadherin and
Hakim SG; Taubitz C; Hoppe S; Steller D; Rades D; Ribbat-Idel J; Alsharif U; Falougy M
Front Oncol; 2023; 13():1151879. PubMed ID: 37265789
[TBL] [Abstract][Full Text] [Related]
2. Immunoexpression of Epithelial Mesenchymal Transition Proteins E-Cadherin, β-Catenin, and N-Cadherin in Oral Squamous Cell Carcinoma.
Angadi PV; Patil PV; Angadi V; Mane D; Shekar S; Hallikerimath S; Kale AD; Kardesai SG
Int J Surg Pathol; 2016 Dec; 24(8):696-703. PubMed ID: 27312520
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Prediction of Oral Squamous Cell Carcinoma by E-Cadherin and N-Cadherin Expression in Overall Cells in Tumor Nests or Tumor Cells at the Invasive Front.
Ozaki-Honda Y; Seki S; Fujiwara M; Matsuura M; Fujita S; Ikeda H; Umeda M; Ayuse T; Ikeda T
Cancer Microenviron; 2017 Dec; 10(1-3):87-94. PubMed ID: 29098659
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-Mesenchymal Transition Predicts Survival in Oral Squamous Cell Carcinoma.
Wangmo C; Charoen N; Jantharapattana K; Dechaphunkul A; Thongsuksai P
Pathol Oncol Res; 2020 Jul; 26(3):1511-1518. PubMed ID: 31471883
[TBL] [Abstract][Full Text] [Related]
5. Expression of epithelial-mesenchymal transition markers at the invasive front of oral squamous cell carcinoma.
Costa LC; Leite CF; Cardoso SV; Loyola AM; Faria PR; Souza PE; Horta MC
J Appl Oral Sci; 2015; 23(2):169-78. PubMed ID: 26018309
[TBL] [Abstract][Full Text] [Related]
6. The immunohistochemical investigations of cadherin "switch" during epithelial-mesenchymal transition of tongue squamous cell carcinoma.
Afrem MC; Mărgăritescu C; Crăiţoiu MM; Ciucă M; Şarlă CG; Cotoi OS
Rom J Morphol Embryol; 2014; 55(3 Suppl):1049-56. PubMed ID: 25607384
[TBL] [Abstract][Full Text] [Related]
7. Subcellular localization and expression of E-cadherin and SNAIL are relevant since early stages of oral carcinogenesis.
Lopes NM; Xavier FCA; Ortiz RC; Amôr NG; Garlet GP; Lara VS; Batista AC; Costa NL; Rodini CO
Pathol Res Pract; 2018 Aug; 214(8):1185-1191. PubMed ID: 29970306
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical Expression of Epithelial Mesenchymal Transition Proteins in Squamous Cell Carcinoma of the Oral Cavity.
Kadeh H; Saravani S; Miri Moghaddam E
Iran J Pathol; 2021; 16(4):354-361. PubMed ID: 34567183
[TBL] [Abstract][Full Text] [Related]
9. Invasive Front Grading and Epithelial-Mesenchymal Transition in Canine Oral and Cutaneous Squamous Cell Carcinomas.
Nagamine E; Hirayama K; Matsuda K; Okamoto M; Ohmachi T; Uchida K; Kadosawa T; Taniyama H
Vet Pathol; 2017 Sep; 54(5):783-791. PubMed ID: 28494700
[TBL] [Abstract][Full Text] [Related]
10. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome.
Pyo SW; Hashimoto M; Kim YS; Kim CH; Lee SH; Johnson KR; Wheelock MJ; Park JU
J Craniomaxillofac Surg; 2007 Jan; 35(1):1-9. PubMed ID: 17296306
[TBL] [Abstract][Full Text] [Related]
11. Utilization of E-cadherin by monocytes from tumour cells plays key roles in the progression of bone invasion by oral squamous cell carcinoma.
Quan J; Du Q; Hou Y; Wang Z; Zhang J
Oncol Rep; 2017 Aug; 38(2):850-858. PubMed ID: 28656299
[TBL] [Abstract][Full Text] [Related]
12. Bovine lactoferrin reverses programming of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition in oral squamous cell carcinoma.
Chea C; Miyauchi M; Inubushi T; Okamoto K; Haing S; Nguyen PT; Imanaka H; Takata T
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):142-147. PubMed ID: 30415774
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma.
da Silva SD; Morand GB; Alobaid FA; Hier MP; Mlynarek AM; Alaoui-Jamali MA; Kowalski LP
Clin Exp Metastasis; 2015 Jan; 32(1):55-63. PubMed ID: 25433796
[TBL] [Abstract][Full Text] [Related]
14. Over-expression of integrin-linked kinase correlates with aberrant expression of Snail, E-cadherin and N-cadherin in oral squamous cell carcinoma: implications in tumor progression and metastasis.
Zhao D; Tang XF; Yang K; Liu JY; Ma XR
Clin Exp Metastasis; 2012 Dec; 29(8):957-69. PubMed ID: 22638656
[TBL] [Abstract][Full Text] [Related]
15. P-cadherin expression reduced in squamous cell carcinoma of the oral cavity: an indicatior of poor prognosis.
Muñoz-Guerra MF; Marazuela EG; Fernández-Contreras ME; Gamallo C
Cancer; 2005 Mar; 103(5):960-9. PubMed ID: 15685613
[TBL] [Abstract][Full Text] [Related]
16. CD147 promotes proliferation and migration of oral cancer cells by inhibiting junctions between E-cadherin and β-catenin.
Min A; Xiong H; Wang W; Hu X; Wang C; Mao T; Yang L; Huang D; Xia K; Su T
J Oral Pathol Med; 2020 Nov; 49(10):1019-1029. PubMed ID: 32740991
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological significance of ZEB-1 and E-cadherin proteins in patients with oral cavity squamous cell carcinoma.
Yao X; Sun S; Zhou X; Zhang Q; Guo W; Zhang L
Onco Targets Ther; 2017; 10():781-790. PubMed ID: 28243114
[TBL] [Abstract][Full Text] [Related]
18. A switch from epithelial to mesenchymal properties correlates with lymphovascular invasion in squamous cell carcinoma of the penis.
May M; Brookman-May S; Burger M; Koch S; Otto W; Bründl J; Albrecht K; Denzinger S
Pathol Res Pract; 2015 Sep; 211(9):641-5. PubMed ID: 26092595
[TBL] [Abstract][Full Text] [Related]
19. Epithelial to mesenchymal transition (EMT) biomarkers--E-cadherin, beta-catenin, APC and Vimentin--in oral squamous cell carcinogenesis and transformation.
Chaw SY; Abdul Majeed A; Dalley AJ; Chan A; Stein S; Farah CS
Oral Oncol; 2012 Oct; 48(10):997-1006. PubMed ID: 22704062
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of E-Cadherin Is a Favorable Prognostic Biomarker in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
Lorenzo-Pouso AI; Silva FFE; Pérez-Jardón A; Chamorro-Petronacci CM; Oliveira-Alves MG; Álvarez-Calderón-Iglesias Ó; Caponio VCA; Pinti M; Perrotti V; Pérez-Sayáns M
Biology (Basel); 2023 Feb; 12(2):. PubMed ID: 36829516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
